Hypoalbuminemia in status epilepticus is a biomarker of short‐ and long‐term mortality: A 9‐year cohort study
Hypoalbuminemia is an easily measurable biomarker reflecting the overall patient's condition and is independently related to short- and long-term SE mortality. Integrating hypoalbuminemia into the STESS (A-STESS) significantly enhances mortality prediction. Future studies are needed to externally validate the A-STESS and evaluate the benefits of albumin supplementation in SE patient prognosis.
Authors
- Hervé Quintard (ORCID: https://orcid.org/0000-0002-3870-6370)
- Andrea O. Rossetti (ORCID: https://orcid.org/0000-0002-7878-172X)
- Karl Schaller (ORCID: https://orcid.org/0000-0002-3848-0789)
- Francesco Misirocchi (ORCID: https://orcid.org/0000-0001-8730-4397)
- Pia De Stefano (ORCID: https://orcid.org/0000-0002-7979-0994)
- Irene Florindo (ORCID: https://orcid.org/0000-0002-1314-5706)
- Margitta Seeck (ORCID: https://orcid.org/0000-0002-6702-0167)
- Oana E. Sarbu
- Andreas Kleinschmidt (ORCID: https://orcid.org/0000-0002-8094-0830)
Institutions
- University of Geneva (CH)
- University of Parma (IT)
- University Hospital of Geneva (CH)
- University of Lausanne (CH)
Publication Details
- Journal
- European Journal of Neurology
- Published
- 2024-12-22
- DOI
- https://doi.org/10.1111/ene.16573
- Citations
- 8
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.08